Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $34,900 - $39,044
-414 Reduced 12.17%
2,987 $275,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $6,093 - $8,027
-84 Reduced 2.41%
3,401 $324,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $13,761 - $17,340
223 Added 6.84%
3,485 $265,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $5,126 - $6,910
74 Added 2.32%
3,262 $225,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $5,718 - $6,507
-77 Reduced 2.36%
3,188 $263,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $56,279 - $72,050
-824 Reduced 20.15%
3,265 $243,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $88,135 - $114,800
1,070 Added 35.44%
4,089 $338,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $3,892 - $5,772
-45 Reduced 1.47%
3,019 $287,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $329,942 - $415,308
-3,236 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $2,263 - $2,828
27 Added 0.84%
3,236 $335,000
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $15,736 - $18,134
-200 Reduced 5.87%
3,209 $268,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $98,286 - $125,076
-1,371 Reduced 28.68%
3,409 $311,000
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $2,486 - $3,235
37 Added 0.78%
4,780 $382,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $169,110 - $226,156
2,939 Added 162.92%
4,743 $328,000
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $4,874 - $7,533
93 Added 5.44%
1,804 $340,000
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $8,962 - $10,261
-125 Reduced 6.81%
1,711 $399,000
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $113,005 - $138,489
1,836 New
1,836 $404,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $34,028 - $43,416
-915 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $24,937 - $29,069
-738 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $26,782 - $28,656
738
738 $81,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.